Active	Status	Sponsor type	Region	Phase	Filter
2 Active 0 Inactive 2 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

2 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Pang, Chenguang
NCT05605613: PD-1 Antibody in Addition to BACE in Patients With NSCLC: A Randomised Controlled Trial	Recruiting	2/3	150	RoW	PD-1 Antibody, PD-1 Inhibitors, BACE	Xuhua Duan	NSCLC	11/23	12/25
NCT06023147: A Real-world Study of the Short-term Efficacy and Safety of E-TACE in Patients With Hepatocellular Carcinoma (HCC)	Not yet recruiting	N/A	298	RoW	E-TACE	Xuhua Duan	Hepatocellular Carcinoma	09/24	09/25